Table 1. AURKA mRNA expression level in BC compared to normal tissues (Oncomine) in 12 datasets.

BC Subtype	Fold-change	P-value	Rank (%)	Sample	Source
Ductal BC	9.423	1.18 × 10-14	1	47	(Richardson et al., 2006)
Medullary BC	4.706	7.88 × 10-19	1	2136	(Curtis et al., 2012)
Invasive Ductal BC	3.168	4.88 × 10-120	1	2136	(Curtis et al., 2012)
Invasive Lobular BC	2.115	5.80 × 10-44	2	2136	(Curtis et al., 2012)
Invasive Ductal & Invasive Lobular BC	2.339	1.02 × 10-31	2	2136	(Curtis et al., 2012)
Invasive BC	2.586	9.96 × 10-7	3	2136	(Curtis et al., 2012)
Mucinous BC	2.137	8.28 × 10-16	3	593	TCGA, 2011
Invasive Ductal BC	4.702	5.39 × 10-53	1	593	TCGA, 2011
Invasive BC	3.468	5.83 × 10-26	1	593	TCGA, 2011
Invasive Lobular BC	2.351	7.20 × 10-14	2	64	TCGA, 2011
Invasive Ductal BC	2.154	2.34 × 10-7	4	64	(Zhao et al., 2004)
Invasive Breast Carcinoma Stroma	–11.071	2.11 × 10-30	2	59	(Finak et al., 2008)

Notes: P-value was analyzed using the t-test. The P-values indicate that the difference was statistically significant between the BC and normal tissue group. Abbreviations: BC, breast carcinoma. mRNA levels of AURKA in different subtypes of BC.